Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 6651-6700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05650879
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
198 participants
Started: Mar 20, 2023 · Completed: Jul 31, 2026
4 conditions
1 sponsor
39 locations
NCT05740930
Effectiveness and Safety of Partition Multi-point Defocused Myopia Management Spectacle Lens in Myopia Control
NA
Active, not recruiting
194 participants
Started: Mar 20, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05676645
Pharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant Pairs
N/A
Active, not recruiting
30 participants
Started: Mar 20, 2023 · Completed: Dec 25, 2026
1 condition
3 sponsors
1 location
NCT05524987
Addressing HyperteNsion and Diabetes Through Community-Engaged Systems in Puno, Peru (ANDES Study)
NA
Active, not recruiting
1,068 participants
Started: Mar 20, 2023 · Completed: Sep 30, 2026
2 conditions
6 sponsors
1 location
NCT06158230
Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.
PHASE2
Active, not recruiting
140 participants
Started: Mar 19, 2023 · Completed: Jan 15, 2024
1 condition
1 sponsor
1 location
NCT05778656
Cardiovascular Risk Prevention With a Mediterranean Dietary Pattern Reduced in Saturated Fat
NA
Active, not recruiting
156 participants
Started: Mar 19, 2023 · Completed: Sep 1, 2025
1 condition
6 sponsors
1 location
NCT05738837
An Evaluation of a Sexual Assault Resistance Program for Adolescent Girls
NA
Active, not recruiting
900 participants
Started: Mar 18, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05766501
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)
PHASE3
Active, not recruiting
650 participants
Started: Mar 17, 2023 · Completed: Sep 6, 2028
1 condition
1 sponsor
95 locations
NCT06683053
Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department
PHASE3
Active, not recruiting
90 participants
Started: Mar 17, 2023 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT06815757
İnvestigating Dysphagia in Pediatric Dystonia
N/A
Active, not recruiting
25 participants
Started: Mar 17, 2023 · Completed: Apr 17, 2025
1 condition
1 sponsor
1 location
NCT05898698
Prospective Case Registry for Wounds
N/A
Active, not recruiting
300 participants
Started: Mar 17, 2023 · Completed: Dec 17, 2025
1 condition
1 sponsor
1 location
NCT05477147
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
NA
Active, not recruiting
92 participants
Started: Mar 17, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
19 locations
NCT05793593
A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer
NA
Active, not recruiting
80 participants
Started: Mar 17, 2023 · Completed: Mar 31, 2026
1 condition
2 sponsors
7 locations
NCT06667271
Clinical Evaluation of Direct and Indirect Composites
N/A
Active, not recruiting
90 participants
Started: Mar 16, 2023 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT05791812
Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE
NA
Active, not recruiting
20 participants
Started: Mar 16, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05662865
Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers
PHASE1
Active, not recruiting
9 participants
Started: Mar 16, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05615311
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
PHASE1/PHASE2
Active, not recruiting
126 participants
Started: Mar 16, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05612035
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
PHASE2
Active, not recruiting
120 participants
Started: Mar 16, 2023 · Completed: Oct 7, 2029
2 conditions
1 sponsor
84 locations
NCT07154810
Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination
N/A
Active, not recruiting
23 participants
Started: Mar 16, 2023 · Completed: Apr 14, 2031
3 conditions
1 sponsor
1 location
NCT05624554
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
PHASE3
Active, not recruiting
300 participants
Started: Mar 16, 2023 · Completed: Mar 17, 2031
2 conditions
1 sponsor
97 locations
NCT05809934
A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
PHASE2
Active, not recruiting
220 participants
Started: Mar 15, 2023 · Completed: Sep 17, 2025
1 condition
1 sponsor
164 locations
NCT05456139
Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care
NA
Active, not recruiting
240 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
8 locations
NCT06486402
DISPARITY Study: An Observational Evaluation of Characteristics of Participants in Clinical Studies
N/A
Active, not recruiting
5,000 participants
Started: Mar 15, 2023 · Completed: Dec 1, 2024
2 conditions
1 sponsor
1 location
NCT05828680
Circadian Rhythm Disruption in the Hospital Intensive Care Environment
N/A
Active, not recruiting
15 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT05545514
Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections
PHASE4
Active, not recruiting
220 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2026
1 condition
3 sponsors
1 location
NCT05613868
TPN-101 in Aicardi-Goutières Syndrome (AGS)
PHASE2
Active, not recruiting
16 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
5 locations
NCT05763719
Pathways to Improved Adolescent Mental Health in Conflict Affected Families
NA
Active, not recruiting
3,024 participants
Started: Mar 15, 2023 · Completed: Jul 1, 2026
2 conditions
4 sponsors
1 location
NCT05715268
Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study
NA
Active, not recruiting
20 participants
Started: Mar 15, 2023 · Completed: Sep 25, 2025
2 conditions
2 sponsors
1 location
NCT05651282
Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer
PHASE4
Active, not recruiting
250 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05763810
Comparing Different Regional Blocks for Analgesia After Off-pump Cardiac Surgery
NA
Active, not recruiting
22 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06958354
Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients
N/A
Active, not recruiting
1,529 participants
Started: Mar 15, 2023 · Completed: Jun 1, 2025
5 conditions
1 sponsor
1 location
NCT05776303
Good Bowls: Eat Well At Work
NA
Active, not recruiting
240 participants
Started: Mar 15, 2023 · Completed: Jul 31, 2025
2 conditions
5 sponsors
1 location
NCT05662397
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
PHASE1/PHASE2
Active, not recruiting
77 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
14 locations
NCT05457556
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
PHASE3
Active, not recruiting
435 participants
Started: Mar 15, 2023 · Completed: Jun 30, 2026
4 conditions
1 sponsor
63 locations
NCT05481931
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
N/A
Active, not recruiting
756 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT05775289
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
182 participants
Started: Mar 15, 2023 · Completed: Jun 1, 2026
1 condition
1 sponsor
50 locations
NCT06992765
Evaluation of Green Tea for Improving Blood Lipid Profile
NA
Active, not recruiting
38 participants
Started: Mar 15, 2023 · Completed: Aug 30, 2025
1 condition
2 sponsors
1 location
NCT05732402
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
PHASE1/PHASE2
Active, not recruiting
72 participants
Started: Mar 15, 2023 · Completed: Mar 2, 2028
4 conditions
1 sponsor
30 locations
NCT05744427
Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
725 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
34 locations
NCT06202950
Type 1 Diabetes,Mindfulness,Yoga,Stress,Health Quality,Glycemic İndex
NA
Active, not recruiting
90 participants
Started: Mar 15, 2023 · Completed: Jul 15, 2025
2 conditions
1 sponsor
2 locations
NCT05358171
Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis
NA
Active, not recruiting
20 participants
Started: Mar 15, 2023 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT05671822
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
PHASE2
Active, not recruiting
76 participants
Started: Mar 14, 2023 · Completed: Jul 30, 2026
1 condition
1 sponsor
1 location
NCT05743842
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning
NA
Active, not recruiting
19 participants
Started: Mar 14, 2023 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05651542
A Comprehensive Self-Management Intervention for Individuals with Inflammatory Bowel Disease
NA
Active, not recruiting
54 participants
Started: Mar 14, 2023 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT05766683
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
PHASE1
Active, not recruiting
20 participants
Started: Mar 14, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05890014
Effects of Diet on Perinatal Mood and Cognition
NA
Active, not recruiting
60 participants
Started: Mar 14, 2023 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT05370352
Mobile Chat Messaging for Smoking Relapse Prevention
NA
Active, not recruiting
590 participants
Started: Mar 14, 2023 · Completed: Sep 30, 2025
1 condition
4 sponsors
2 locations
NCT05844852
P200TE US Reference Database Study
NA
Active, not recruiting
800 participants
Started: Mar 14, 2023 · Completed: May 1, 2024
1 condition
1 sponsor
9 locations
NCT05633602
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
PHASE3
Active, not recruiting
838 participants
Started: Mar 14, 2023 · Completed: Mar 15, 2028
2 conditions
4 sponsors
566 locations
NCT05626049
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
NA
Active, not recruiting
1,800 participants
Started: Mar 14, 2023 · Completed: Jun 30, 2026
1 condition
8 sponsors
3 locations
Previous
1
More pages
131
132
133
134
135
136
137
More pages
431
Next